Menu Menu

Drug consumption rooms could save thousands of British lives

The world’s largest review of drug consumption rooms reveals that they are integral to harm-reduction and could slash the transmission of fatal diseases. In addition, they may help reduce pressure on ambulance callouts and the burden on UK hospitals.

Data published by the Office for National Statistics shows that the number of drug-related deaths in England and Wales has risen for the eleventh year in a row, with 4,907 (equivalent to 84.4 fatalities per million people) overdoses registered in 2022, the highest since records began in 1993.

Conscious that current harm-reduction methods are failing nation-wide, the UK government has part-funded a study examining the effectiveness of drug-consumption rooms and overdose-prevention centres (OPCs.

The largest review of its kind, it reveals that thousands of lives could be saved if facilities designed to supervise people while they get high were set up in British cities.

It also found that they could slash the transmission of fatal diseases, as well as reduce litter, the pressure on ambulance callouts, and the burden on hospitals.

The latter would be significantly beneficial for the NHS, which right now is under unbearable strain, with an overall waiting list for treatment of approximately 7.6 million.

At present, such facilities already operate in France, the US, Germany, Canada, Australia, Denmark, Greece, Belgium, Spain, Portugal, Norway, Switzerland, Mexico, Iceland, Luxembourg, Colombia, and the Netherlands.

Each unit hosts from 20 to 400 users a day, with the aim to provide a safe location for people to take drugs in the presence of trained health workers who can intervene if something goes wrong.

They also mean that people don’t have to rush, have access to clean needles, and can get help with other issues, from testing for Hepatitis B and HIV to accessing mental health support.

However, none have been deployed officially in the UK yet, and the report warns that this absence is costing lives. In fact, according to a monitoring project, UK drug users were 13 times more likely to die from an overdose in 2021 compared with the European average.

This is because supplies cut with synthetic opioids known as nitazines (up to 100 times more potent than heroin) are continuing to circulate amid a heroin decline caused by the Afghan Taliban cracking down on poppy farming.

‘OPCs can help save lives in an urgent and growing drug-death crisis in the UK,’ says co-author Dr Gillian Shorter of Queen’s University Belfast, who worked on the research  with academics at the universities of Oxford, Kent, East Anglia, West London and Bristol.

‘Alongside other essential public-health strategies, such as naloxone availability and real-time drug testing, the adoption of OPCs in areas of need will help reduce the enormous costs facing our communities.’

Accessibility